May 17, 2018
Rose
All the buzz over combining experimental immune-boosting drugs with checkpoint inhibitors could fizzle into disappointment. In other public health news: eye treatments, aging athletes, the E. coli outbreak, hearing aids, and Ebola.
from Kaiser Health News https://ift.tt/2IQaMHF
May 17, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
First Edition: June 18, 2019- National Child Well-Being Report Reveals That ‘Racial Inequities Remain Deep, Systemic And Stubbornly Persistent’
- Miracle Machine Makes Heroic Rescues — And Leaves Patients In Limbo
- Database Designed To Compensate People Injured By Vaccines Shows Negative Reactions Are Extraordinarily Rare
- Children’s Hospital To Halt Complex Heart Surgeries Following Shocking Report On Increase In Patients’ Deaths
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment